Nvidia Corporation upgraded to strong buy as AI demand surges. Click for how Q3 revenue growth, rising margins, and solid ...

Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...

Bank of Montreal maintains robust fundamentals, prudent asset diversification, and disciplined loan management. Read why I ...

Micron Technology's soaring profits and margin growth make it a top AI investment pick in 2024–2026. Click for this updated ...

EM equities surged in Q3, yet the Hartford Emerging Markets Equity Fund underperformed its benchmark. Click here to analyze ...

Discover why rising central bank gold buying and EU moves on Russian assets may boost gold's bull market. Click here to read ...

Gold and silver exhibit robust return potential, driven by deeply negative real interest rates and favorable technical ...

Geely Auto (GELYF) has been outpacing a slowing Chinese auto market, delivering 42% YTD unit sales growth versus the sector's ...

Alger Mid Cap 40 ETF (FRTY) delivered a strong 2024, up 37.3%, but exhibits extreme volatility and underperformance since ...

Omega Flex, Inc. is rated a Sell with ongoing fundamental deterioration and limited near-term recovery prospects. Learn more ...

Nektar Therapeutics may have a pipeline-in-a-drug with rezpegaldesleukin, has additional readouts ahead, and cash until 2027.

Discover why Amtech Systems (ASYS) leads with 118% YTD gains and AI-driven growth, but find out why experts advise waiting ...